Diabetes, Prior PCI, and Dual Antiplatelet Therapy
Ticagrelor plus aspirin reduced ischemic events in patients with type 2 diabetes, stable coronary artery disease, and previous percutaneous coronary intervention (PCI), according to a trial published in The Lancet.
Source: JAMA - Category: General Medicine Source Type: research
More News: Angioplasty | Aspirin | Coronary Angioplasty | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Percutaneous Coronary Intervention